News
Important Only
Enlightify Announces Strategic Investment In Cyber Token, Emphasizing Long-Term Commitment To Web3 Infrastructure
July 17 (Reuters) - Enlightify Inc ENFY.N:ENLIGHTIFY INC. ANNOUNCES STRATEGIC INVESTMENT IN CYBER TOKEN, EMPHASIZING LONG-TERM COMMITMENT TO WEB3 INFRASTRUCTUREENLIGHTIFY INC - ANNOUNCES $20 MILLION INVESTMENT IN CYBER TOKENENLIGHTIFY INC - INVESTMENT WILL NOT EXCEED $20 MILLION USING DOLLAR-COST AV...Reuters
Thu, Jul 17
Bank7 Q2 net income rises 7.44% on higher loan growth
OverviewBank7 Q2 net income rises 7.44% to $11.1 mlnEarnings per share increases 7.41% to $1.16Total loans grow 5.17% to $1.5 blnOutlookCompany emphasizes resilience in dynamic geographic marketsResult DriversORGANIC LOAN GROWTH - Bank7 reports strong organic loan growth, contributing to a 5.17% inc...Reuters
Thu, Jul 17
US informs Switzerland about delay in delivery of Patriot systems, says ministry
BERLIN, July 17 (Reuters) - The United States has informed Switzerland about delays to the delivery of Patriot air defence systems, the Swiss defence ministry said in a statement released on Thursday."The United States Department of Defense has informed the (Swiss ministry) that it will repriori...Reuters
Thu, Jul 17
FACTBOX-Zuckerberg's Meta Superintelligence Labs poaches top AI talent in Silicon Valley
July 17 (Reuters) - Meta META.O CEO Mark Zuckerberg has pledged hundreds of billions of dollars towards building massive data centers, days after ratcheting up the AI race with the launch of a division made up of engineers poached from rivals he hopes to challenge. Zuckerbe...Reuters
Thu, Jul 17
Travelers' combined ratio improves to 90.3% in Q2 earnings beat
$6.51 core EPS beats $3.65 consensus and Q2 2024's $2.51Combined ratio improves to 90.3% from 100.2% a year ago$927 million pre-tax cat losses down from $1.51 billion in Q2 2024$315 million favourable prior year reserve development up from $230 millionBusiness insurance renewal premium change de...Reuters
Thu, Jul 17
RPT-BREAKINGVIEWS-Meta’s buy-and-build AI merger lacks synergy
By Jennifer Saba NEW YORK, July 16 (Reuters Breakingviews) - Mark Zuckerberg’s latest merger will be incredibly hard to engineer successfully. The Meta Platforms META.O boss is trying to combine buying and building to turbocharge his ambitions in artificial intelligence. Although he created the ...Reuters
Thu, Jul 17
RPT-BREAKINGVIEWS-Morgan Stanley is sensibly out of fashion
By Stephen Gandel NEW YORK, July 16 (Reuters Breakingviews) - Morgan Stanley MS.N is going out of fashion. The deal consigliere and money manager commanded a 50% valuation premium to Goldman Sachs GS.N three years ago and a smaller one to JPMorgan JPM.N. The gap has narrowed considerably against ...Reuters
Thu, Jul 17
RPT-BREAKINGVIEWS-Couche-Tard should have gone hostile on Seven & i
By Una Galani HONG KONG, July 17 (Reuters Breakingviews) - Be bold and go hostile, or don't bother at all. That's the message Canada's Alimentation Couche-Tard ATD.TO is sending to foreigners eyeing acquisitions of Japanese companies. The company's withdrawal on Wednesday of its $...Reuters
Thu, Jul 17
Clearside Biomedical Inc - All Employees To Transition To Consulting Roles - SEC Filing
Clearside Biomedical Inc CLSD.O:CLEARSIDE BIOMEDICAL INC - ALL EMPLOYEES TO TRANSITION TO CONSULTING ROLES - SEC FILINGCLEARSIDE BIOMEDICAL INC - ESTIMATES $3.4 MILLION IN TERMINATION COSTS - SEC FILINGCLEARSIDE BIOMEDICAL INC: REDUCTION IN FORCE IS EXPECTED TO BE COMPLETED DURING Q3 OF 2025Source t...Reuters
Thu, Jul 17
Velocity Clinical Research Strategic Partnership With Palantir To Automate & Streamline Complex Payments Reconciliation Process In Clinical Trials
Palantir Technologies Inc PLTR.O:VELOCITY CLINICAL RESEARCH: STRATEGIC PARTNERSHIP WITH PALANTIR TO AUTOMATE & STREAMLINE COMPLEX PAYMENTS RECONCILIATION PROCESS IN CLINICAL TRIALSReuters
Thu, Jul 17
Clearside Biomedical Announces Plan To Explore Strategic Alternatives To Advance Its Proprietary Suprachoroidal Space (Scs®) Delivery Platform And Promising Ophthalmology Pipeline
Clearside Biomedical Inc CLSD.O:CLEARSIDE BIOMEDICAL ANNOUNCES PLAN TO EXPLORE STRATEGIC ALTERNATIVES TO ADVANCE ITS PROPRIETARY SUPRACHOROIDAL SPACE (SCS®) DELIVERY PLATFORM AND PROMISING OPHTHALMOLOGY PIPELINECLEARSIDE BIOMEDICAL INC: ALTERNATIVES COULD INCLUDE SALE, LICENSE, MONETIZATION, DIVESTI...Reuters
Thu, Jul 17
Morien Receives Notice From Kameron To Explore Sale Of Donkin Mine Interest
Morien Resources Corp MOX.V:MORIEN RECEIVES NOTICE FROM KAMERON TO EXPLORE SALE OF DONKIN MINE INTERESTMORIEN RECEIVES NOTICE FROM KAMERON TO EXPLORE SALE OF DONKIN MINE INTERESTMORIEN RESOURCES CORP - HOLDS 2-4% ROYALTY ON DONKIN MINE COAL SALESReuters
Thu, Jul 17
Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate
SK Bioscience Co Ltd 302440.KS:SK BIOSCIENCE SUBMITS IND FOR PHASE 1/2 CLINICAL TRIAL OF ADJUVANTED INFLUENZA VACCINE CANDIDATESK BIOSCIENCE CO LTD - INTERIM RESULTS FROM PHASE 1/2 TRIAL EXPECTED BY 2027Reuters
Thu, Jul 17
Harrow Enters Into Commercialization Agreement With Samsung Bioepis For Ophthalmology Biosimilars Portfolio In The United States
Harrow Inc HROW.O:HARROW ENTERS INTO COMMERCIALIZATION AGREEMENT WITH SAMSUNG BIOEPIS FOR OPHTHALMOLOGY BIOSIMILARS PORTFOLIO IN THE UNITED STATESHARROW INC - TO ASSUME COMMERCIAL RESPONSIBILITY FOR BYOOVIZ AND OPUVIZ BY 2025HARROW INC - GAINS EXCLUSIVE U.S. RIGHTS TO OPHTHALMIC BIOSIMILARSReuters
Thu, Jul 17
